IP Library Patent Application 14932410
Patent Application
App. No. 14/932,410

TRANSOBTURATOR METHODS FOR INSTALLING SLING TO TREAT INCONTINENCE, AND RELATED DEVICES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/932,410
Abstract

Described are methods of treating urinary incontinence using a urinary sling and a tissue path that passes through the obturator foramen, along with related surgical implants, devices, systems, and kits.

Claims (45)

1 . A method of treating incontinence comprising the steps of:

providing an elongate implantable sling comprising a central support portion and elongate end portions sized and shaped to extend between an incision substantially adjacent to a patient's obturator foramen, through the obturator foramen, and to a location below the urethra,

creating a pair of lateral incisions substantially adjacent a patient's left and right obturator foramen,

creating a medial incision at the perineum,

exposing bulbospongiosus muscle,

dissecting bulbospongiosus muscle to expose corpus spongiosum,

placing the central support portion to contact the corpus spongiosum, and

extending the end portions internally through the obturator foramen to the lateral incisions substantially adjacent to the obturator foramen.

2 . The method of claim 1 , comprising

providing a left-hand surgical tool comprising a needle portion extending from a handle, the needle portion comprising a three-dimensional portion having structure in three dimensions and sized and shaped to extend between a patient's right-side lateral incision, through the obturator foramen, and to the medial incision,

inserting a distal end of the left-hand tool through the right-side lateral incision, through a patient's right-side obturator foramen, and to the medial incision,

associating an end of the sling with the distal end of the left-hand tool at the medial incision,

drawing the end of the sling through the right-side obturator foramen to the right-side lateral incision,

providing a right-hand surgical tool comprising a needle portion extending from a handle, the needle portion comprising a three-dimensional portion having structure in three dimensions and sized and shaped to extend between a patient's left-side lateral incision, through the obturator foramen, and to the medial incision,

inserting a distal end of the right-hand tool through the left-side lateral incision, through a patient's left-side obturator foramen, and to the medial incision,

associating an end of the sling with the distal end of the right-hand tool at the medial incision,

drawing the end of the sling through the left-side obturator foramen to the left-side lateral incision.

3 . The method of claim 1 , comprising placing tension on the end portions of the sling to approximate pelvic tissue.

4 . The method of claim 3 , comprising approximating the urethra in a proximal direction.

5 . The method of claim 3 , comprising approximating the urethra in a proximal direction by a distance in the range from 1 to 5 centimeters.

6 . The method of claim 1 , comprising

creating tissue paths between each lateral incision and the medial incision, exiting in the perineal region between the corpus cavernosum and the corpus spongiosus,

placing the central support portion in contact with the corpus spongiosum at as location from 0.5 to 1.5 centimeters distal to a line created between needle passages on both sides of the corpus spongiosum, and

placing tension on the end portions of the sling to approximate the corpus spongiosum.

7 . The method of claim 1 , wherein the patient is affected by a condition of perineal descent.

8 . The method of claim 1 , wherein the patient has experienced radical prostatectomy, a TURP (trans-urethral resection of the prostate), or a cystectomy.

9 . The method of claim 1 , wherein the approximating step repositions pelvic tissue to place a urethra to a more physiologically correct position relative to improve coaptation of the urethra by the rhabdosphincter.

10 . The method of claim 1 , wherein prior to the surgical procedure the patient exhibits residual sphincter function.

11 . The method of claim 1 , comprising

contacting the central support portion to the corpus spongiosum, and

after placement of the central support portion and the end portions, placing tension on the end portions of the sling to approximate tissue selected from the rhabdosphincter, the urethra, and a combination of these.

12 . The method of claim 1 , wherein the implant comprises a widened central support portion, and the method comprises placing the widened central support portion below the corpus spongiosum.

13 . The method of claim 12 , comprising securing the widened central support portion to the corpus spongiosum.

14 . The method of claim 13 , comprising securing the widened central support portion to the corpus spongiosum by use of a suture.

15 . A method of treating incontinence, the method comprising installing a supportive sling below the bulbous urethra.

16 . The method of claim 15 , comprising placing tension on the sling to approximate pelvic tissue including the urethra, to improve sphincter function and coaptation of the urethra.

17 . The method of claim 15 , wherein the sling is placed in contact with the corpus spongiosum.

18 . The method of claim 15 , comprising dissecting a tissue path that traverses the obturator foramen and passing an end portion of the sling trough the tissue path traversing the obturator foramen.

19 . The method of claim 15 , comprising

providing an elongate implantable sling comprising a central support portion and elongate end portions,

creating an incision at the perineum,

exposing bulbospongiosus muscle,

dissecting bulbospongiosus muscle to expose corpus spongiosum,

placing the central support portion to contact the corpus spongiosum.

20 . The method of claim 19 , wherein the implant comprise a widened central support portion, and the method comprises placing the widened central support portion below the corpus spongiosum.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2018
From: ASTORA WOMEN'S HEALTH, LLC
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 045031/0964 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2018
From: BOSTON SCIENTIFIC CORPORATION
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 045029/0058 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CHANGE OF NAME Recorded Jan 11, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 037477/0028 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037477/0886 →
CHANGE OF NAME Recorded Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037478/0444 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2016
From: GOZZI, CHRISTIAN; REHDER, PETER
To: AMS RESEARCH CORPORATION
Reel/Frame 037453/0673 →